Literature DB >> 19500570

Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

A Grünewald1, M E Gegg, J-W Taanman, R H King, N Kock, C Klein, A H V Schapira.   

Abstract

Mutations of the PINK1 gene are a cause of autosomal recessive Parkinson's disease (PD). PINK1 encodes a mitochondrial kinase of unknown function which is widely expressed in both neuronal and non-neuronal cells. We have studied fibroblast cultures from four family members harbouring the homozygous p.Q456X mutation in PINK1, three of their wild-type relatives, one individual with the homozygous p.V170G mutation and five independent controls. Results showed bioenergetic abnormalities involving decreased activities of complexes I and IV along with increased activities of complexes II and III in the missense p.V170G mutant. There were increased basal levels of mitochondrial superoxide dismutase in these cells and an exaggerated increase of reduced glutathione in response to paraquat-induced free radical formation. Furthermore, swollen and enlarged mitochondria were observed in this sample. In the p.Q456X nonsense mutants, the respiratory chain enzymes were unaffected, but ATP levels were significantly decreased. These results confirm that mutations of PINK1 cause abnormal mitochondrial morphology, bioenergetic function and oxidative metabolism in human tissues but suggest that the biochemical consequences may vary between mutations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500570     DOI: 10.1016/j.expneurol.2009.05.027

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  44 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.

Authors:  Tomohiro Nakamura; Piotr Cieplak; Dong-Hyung Cho; Adam Godzik; Stuart A Lipton
Journal:  Mitochondrion       Date:  2010-05-04       Impact factor: 4.160

Review 3.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

Review 4.  Mitochondrial dynamics: the intersection of form and function.

Authors:  Andrew Ferree; Orian Shirihai
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 5.  Dynamin-related protein-1 as potential therapeutic target in various diseases.

Authors:  Surinder Singh; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

Review 6.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

Review 7.  Aetiopathogenesis of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

Review 8.  Mendelian neurodegenerative disease genes involved in autophagy.

Authors:  Lidia Wróbel; Sandra Malmgren Hill; Claudia Puri; Sung Min Son; Motoki Fujimaki; Ye Zhu; Eleanna Stamatakou; Farah Siddiqi; Marian Fernandez-Estevez; Marco M Manni; So Jung Park; Julien Villeneuve; David Chaim Rubinsztein
Journal:  Cell Discov       Date:  2020-05-05       Impact factor: 10.849

9.  The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.

Authors:  Teresa G Hastings
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

Review 10.  The mitochondrial kinase PINK1, stress response and Parkinson's disease.

Authors:  Marina Jendrach; Suzana Gispert; Filomena Ricciardi; Michael Klinkenberg; Rudolf Schemm; Georg Auburger
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.